is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
24 & 25 January 2024
Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
Pharmapack’s Start-up Hub helps ambitious innovators make their mark on the world of pharma. Innovators just like you. Whether you’re looking for investment, mentorship, or exposure to new partners, Pharmapack is the ideal platform to support your next step.
For any questions please reach out to [email protected]
Pharmapack has earned the trust of thousands of pharma industry professionals from around the world. With 300+ exhibitors and almost 5,000 on-site attendees, Pharmapack Europe is the perfect place to meet people passionate about start-up companies like yours.
Innovation is central to the packaging and drug delivery sector, and start-up companies are key drivers of new products, technologies and solutions. At Pharmapack Europe, we are committed to forging new partnerships between start-ups and pharma companies to enable a sustainable pipeline of innovation.
As part of our commitment to innovation, we are lucky to be working with some key thought leaders to help nurture and cultivate our start-ups through mentoring and consultative opportunities. We hope this provides a forum to be able to network with peers, learn about the latest market innnovations and work closely with the pharma companies of tomorrow.
If you would like to join the panel or speak more about start-up opportunities at Pharmapack, please reach out to [email protected]
Startup Program Manager - Healthcare
Alice began her career in academic research between Paris and Montreal, where she studied the therapeutic properties of mesenchymal stem cells in autoimmune diseases. Willing to investigate how open innovation is transforming healthcare, she evolved within the industrial and entrepreneurial ecosystems to connect institutional and industrial players to impactful innovations. As a Startup Program Manager within Paris&Co, one of the largest networks of incubators in Europe, she has mentored over 30 healthtech startups to help them refine their business and product development strategies, identify new partnership opportunities, and ultimately grow in a demanding global market. Doctor of Pharmacy, Alice completed a master's of Biology at the University Paris-Cité and held a Master of Science in Biotechnology from Paris-Saclay University.
Anand has 25 years of healthcare experience including 20 years of active investment experience in venture capital, growth capital, private equity investments, LBOs, MBOs & secondary market transactions in healthcare.
Govin Capital is a Singapore-based Investment Company that invests in early-stage innovative companies in Digital Healthcare, Artificial Intelligence, IOT & EdTech Startups. The companies have a scalable business model and backed by a strong management team. We focus on Singapore, US and Indian markets. To-date, Govin Capital has made several investments and incubated several Startups. Govin Capital is funded by Institutional investors and Family Offices from Europe, USA, India and Singapore.
Digital Pharma Lab
d2a / Digital Pharma Lab
Cofounder and Program Director
Cofounder and Program Director of d2a / Digital Pharma Lab, the first independent Pharmatech accelerator that initiates collaborative projects between pharmaceutical companies and pharmatech digital startups.
With this agile and innovative approach, we have able to create multiple collaborations and contracts between Pharmatech companies and Pharma companies.
Didier Tranchier has a strong entrepreneurial experience and used to be an investor in digital startups with a portfolio of more than 30 investments ranging from seed stage to IPO; he is also a member of several boards of directors.
Co-founder and Venture Partner
Kevin is a co-founder and Venture Partner at Medicxi. Prior to Medicxi, Kevin was a Partner at Index Ventures for 13 years, having joined in 2003. Kevin originated Index’s first asset-centric investment in PanGenetics (acquired by Abbott) and led Medicxi’s investment in Impact Biomedicines (acquired by Celgene). Kevin currently serves on the board of Levicept.
Prior to joining Index, Kevin was with Cambridge Antibody Technology (CAT) where he was appointed Head of Research in 1994 and then Research Director and Chief Technology Officer in 1997. Kevin led the development of CAT's platform technologies and oversaw their application in the discovery of a number of human antibodies - two of which are now marketed worldwide: Humira (by Abbott Pharmaceuticals) and Benlysta (by GlaxoSmithKline). Kevin was part of the management team that floated CAT on the London Stock Exchange (subsequently acquired by AstraZeneca).
Kevin received a BSc in Molecular Biology from Edinburgh University and a PhD in Pathology from Cambridge University. He also acts as chairman of Crescendo Biologics.
Vice President - Healthcare Advisory
Head of M&A Lead Advisory
Marc Chevalier holds a PhD in Neuroscience. He is strongly involved in building bridges between PhDs and ecosystems outside academia in order to increase the opportunities for PhDs to succeed in their careers. He has been Career Advisor at the Institut Pasteur and Responsible for Entrepreneurship and Startup Creation in the Institut Pasteur and the Imagine Institute of Genetic Disease prior becoming Director of Innovation of the Lyric Institute. He is now entrepreneur (CEO of NeckEpur) and he is continuing guiding scientists and professionals in the transition from Research to Development & Innovation (RDI), startup creation & developing their entrepreneurial mindset as well as the development of their career.
VINC – The Capital Of Life
Founder and Managing Partner
Thomas is a successful life science corporate finance advisor, capital sourcing expert, investor and mentor. With his large network and long-standing experience in working with Life Sciences companies he’s a trusted partner to his clients. Building bridges between company owners and investors, constructing compelling equity stories, deal moderation and negotiation are his speciality.
Thomas is a successful life science corporate finance advisor, capital sourcing expert, investor and mentor. With his large network and long-standing experience in working with Life Sciences companies he’s a trusted partner to his business partners and portfolio companies, particularly along the entire bio-pharmaceutical value chain. Building bridges between company owners and investors, constructing compelling equity stories, strategically supporting company owners and C-suite executives, deal moderation and negotiation are his speciality
ESCP Business School
Digital Health Expert - Lecturer
Holding a M.Eng, M.Sc and an MBA, Vincent is a healthcare consultant and entrepreneur with 10 years of experiences in digital health and international relations. Founder of Digital Pharma Lab, the first independant pharmatech accelerator in Europe and Coalition Next, the first public-private health innovation coalition in France. He is driven by being at the intersection of technology and life sciences to serve the unmet needs of patients, caregivers and physicians. International experience in the U.S. and multiple European countries across startups operations management, strategy consulting, government diplomacy and entrepreneurship.
“Innovation has always been so important to Pharmapack and to the entire packaging and drug delivery industry. Start-ups are a great space for innovation to thrive on solution-led thinking and we want to support them when we can. We’re so excited to begin this journey, connecting start-ups with businesses and creating opportunities for innovators to source partnerships at our world-class events.